Navigation Links
Results of Pediatric Clinical Trial of External Trigeminal Nerve Stimulation for the Treatment of ADHD
Date:4/18/2013

LOS ANGELES, April 18, 2013 /PRNewswire/ -- NeuroSigma, Inc., a California-based medical device company, today announced that the results of the first-ever pediatric clinical trial of external Trigeminal Nerve stimulation (eTNS™) for the treatment of attention-deficit hyperactivity disorder (ADHD) will be presented at the American Psychiatric Association annual meeting in San Francisco on May 20, 2013.  The clinical trial was conducted at the University of California, Los Angeles (UCLA) with funding provided by NeuroSigma.

This study, which began in November 2011, was a Phase I open-label trial of children ages 7 to 14 who had a DSM – IV diagnosis of ADHD.  Subjects received eTNS nightly as monotherapy for the 8-week study period.  ADHD symptom severity and cognitive performance were assessed at baseline, four weeks and eight weeks.  The a priori outcome metric was the investigator-completed ADHD rating scale (ADHD-RS scale). 

The results will be presented by James McGough , M.D., M.S., principal investigator for the study and Professor of Clinical Psychiatry at the Semel Institute for Neuroscience and Human Behavior and David Geffen School of Medicine at UCLA, and director of clinical teaching programs in both Child and Adolescent Psychopharmacology and ADHD at UCLA.  Dr. McGough is a leading researcher in the field and has worked to understand ADHD's causes and develop new treatments for nearly two decades. 

"PET scan data that showed the immediate effects of eTNS on activity in centers in the brain associated with attention prompted our interest in exploring eTNS as a treatment for ADHD in children," said Dr. McGough.  "There is a pressing need for non-stimulant options to manage ADHD given parental and patient preferences to avoid medica
'/>"/>

SOURCE NeuroSigma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Abaxis To Report Fourth Quarter And Fiscal Year 2013 Financial Results Thursday, April 25, 2013
2. Quest Diagnostics Reports First Quarter 2013 Financial Results
3. Second ISPE-FDA Event Attracts Top Names, Features Release of Drug Shortage Survey Results
4. Span-America Medical Systems To Release Second Quarter Results On May 1, 2013
5. Mindray to Report First Quarter 2013 Financial Results on May 6, 2013
6. Valeant Pharmaceuticals To Announce 2013 First Quarter Results On May 2, 2013
7. Synthetic Biologics Reports Year End 2012 Financial Results
8. CareFusion to Report Third Quarter Fiscal 2013 Results on May 9
9. Questcor to Report First Quarter Results on April 30, 2013
10. Regeneron to Report First Quarter 2013 Financial and Operating Results and Host Conference Call and Webcast on May 3, 2013
11. Cardinal Health To Release Third-Quarter Results For Fiscal Year 2013 On May 2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015 Pepperl+Fuchs, ... has acquired MACTek Corporation, a leading provider of ... Pepperl+Fuchs, strategy to further extend its integrated solutions ... market.    "We are pleased to ... existing portfolio," said Jim Bolin , Pepperl+Fuchs, ...
(Date:8/31/2015)... , Aug. 31, 2015 Thousands of people ... neglect of the opioid addiction epidemic at dozens of ... term in 2008, the United States ... addiction involving prescription opioids and heroin, yet the President ... a strongly worded letter to President Obama , ...
(Date:8/31/2015)... , August 31, 2015 ... the global cardiovascular monitoring and diagnostic devices market ... predicted to reach a value of approximately US$7.0 ... 9.7% between 2013 and 2019. The title of ... Market (ECG, Holter Monitors, Event Monitors, Cardiovascular Diagnostic ...
Breaking Medicine Technology:Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 4Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 5
(Date:8/31/2015)... Cokato, MN (PRWEB) , ... August 31, 2015 , ... ... Hallmark series line of saunas. Available starting in the 3rd quarter, the newly re-styled ... that assembles quickly without special tools. , These new models include more glass and ...
(Date:8/31/2015)... ... August 31, 2015 , ... Physicians’ Education Resource®, LLC ... Symposium: Innovative Cancer Therapy for Tomorrow® meeting, is seeking abstract submissions for ... York City. The annual legacy meeting uses a variety of formats to educate ...
(Date:8/31/2015)... Louisville, KY (PRWEB) , ... August 31, 2015 ... ... Casper, Wyoming, has selected ezDI’s computer-assisted coding (CAC) software for its Clinical Documentation ... (NLP) engine, ezNLP, and a patent pending ICD-10 solution - ezCAC is an ...
(Date:8/31/2015)... ... August 31, 2015 , ... People with ... a greater risk for injury, potentially because they are more susceptible to the ... School of Public Health analysis discovered. , The research, published online in ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... users to develop skills and assess their competencies in managing challenging conversations, announced ... present at the Defense Centers of Excellence for Psychological Health and Traumatic ...
Breaking Medicine News(10 mins):Health News:Finnleo Introduces Hallmark Series Saunas 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 3Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 4Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 3Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 4Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2
... Medical Plan with Health Savings Accounts and Supplemental Coverage ... The Guardian Life Insurance Company of ... life insurers and a leading provider of employee benefits ... offering a comprehensive, high-deductible healthcare plan that helps employers ...
... will help oncologists guide treatment of patients with ... Biodesix, Inc. today announces U.S. commercial availability of ... with advanced stage non-small cell lung cancer (NSCLC). ... good or poor outcomes following treatment with epidermal ...
... Palin Will Take Part in a Town Hall Meeting ... Teen PregnancyNEW YORK, May 5 The Candie,s Foundation ... its Teen Ambassador. Palin, daughter of Governor Sarah Palin ... and select media interviews to promote May 6th, the ...
... CDC also points to encouraging developments in Mexico, thought to ... News) -- The number of confirmed swine flu cases in ... But, the revised numbers indicate catching up on a backlog ... infections, federal health officials said. , And, while insisting that ...
... Calif., May 5 The recession has forced many ... leaves concerned moms across the U.S. asking, "How will ... children isn,t so much about the quantity of time ... quality," says Dr. Robert Puff, a clinical psychologist based ...
... Automated Hemostasis Analyzer with Chemiluminescent Technology - , BEDFORD, ... that it has received FDA clearance 510(k) for the ... IL to market the ACL AcuStar Hemostasis Testing System, ... The ACL AcuStar is the first specialty-test analyzer that ...
Cached Medicine News:Health News:Guardian Launches Comprehensive, Consumer-Driven Healthcare Program 2Health News:Guardian Launches Comprehensive, Consumer-Driven Healthcare Program 3Health News:Biodesix Advances the Field of Personalized Medicine With the Launch of VeriStrat(R) 2Health News:Biodesix Advances the Field of Personalized Medicine With the Launch of VeriStrat(R) 3Health News:The Candie's Foundation Appoints Bristol Palin As Teen Ambassador 2Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 2Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 3Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 4Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 5Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 6Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 7Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 8Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 9Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 10Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 11Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 12Health News:Mother's Day Blues: When Being a Stay-at-Home Mom Is No Longer an Option 2Health News:Instrumentation Laboratory Launches ACL AcuStar(TM) Hemostasis Testing System 2Health News:Instrumentation Laboratory Launches ACL AcuStar(TM) Hemostasis Testing System 3
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Medicine Products: